Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Abivax Appoints James Berger As Global Head of Marketing

PRIVATESep 07, 2026about 13 hours ago

Position

Head of Marketing

Company

Abivax

James Berger
ParisBiotechnologyHealth CareMedicalTherapeuticsPharmaceuticalConsultingLegalBiopharma

Description

Abivax has announced the appointment of James Berger as Global Head of Marketing. With over 20 years of experience in the biopharmaceutical industry, he will lead the company's commercial strategy and brand development.

Company Information

Company

Abivax

Location

Rue De La Baume

Paris, Ile-de-France, France

About

Abivax is developing therapies that modulate the body’s natural immune system machinery. A clinical-stage company, Abivax leverages its immune enhancing and antiviral platforms to develop drug candidates to treat inflammatory diseases, viral diseases and liver cancer. Abivax is based on innovative research driven by the idea of modulating the body’s natural immune system mechanisms to treat diseases.

Don't miss Abivax's next move

Get an email the moment Abivax changes its leadership, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Suggested for you
Michael
Likely contact at this company
••••••••@••••••••

See Michael's verified email →

Pierre
Senior decision-maker at this company
••••••••@••••••••

See Pierre's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for Abivax 's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Abivax changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.